<DOCUMENT>
<TYPE>EX-10.29
<SEQUENCE>2
<FILENAME>v405690_ex10-29.htm
<DESCRIPTION>EXHIBIT 10.29
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 10.29</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AMENDMENT TO LICENSE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THIS AMENDMENT (<B>&ldquo;Amendment
No. 1&rdquo;)</B> is made as of 23 January 2015 to the License Agreement dated 19<SUP>th</SUP> September 2014 (the <B>&ldquo;License
Agreement&rdquo;</B>) between Plasma Technologies, LLC, (hereinafter referred to as &ldquo;<B>PLASMATECH&rdquo;</B>) a South Carolina
limited liability company with an address c/o Eugene J. Zurlo, 36 Prioleau Street, Unit N, Charleston, SC 29401 and PlasmaTech
Biopharmaceuticals, Inc., a Delaware corporation having a place of business at 1325 Avenue of the Americas, 27<SUP>th</SUP> Floor,
New York, NY USA (<B>&lsquo;LICENSEE&rdquo;</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">PLASMATECH and LICENSEE
are hereinafter referred to as a <B>&ldquo;Party&rdquo;<I> </I></B>and collectively <B>&ldquo;Parties&rdquo;</B> to this Amendment
No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In consideration of the
mutual covenants, terms and conditions set forth below and for other good and valuable consideration which the Parties hereto hereby
acknowledge, the Parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date of this amendment, Section 3.1(a) is amended and restated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.9in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective
Date Payment</U>. In consideration of the rights and licenses granted by PLASMATECH herein, LICENSEE shall deliver to PLASMATECH
a combination of cash and common shares in LICENSEE in the amount of five million dollars ($5,000,000.00). One million dollars
($1,000,000.00) will be paid in cash. The remaining four million dollars ($4,000,000.00) will be paid at the option of the LICENSEE
in cash and/or shares of common stock (such shares of common stock, for this purpose, being valued at the price to the public in
the offering, net of transaction expenses and underwriting fees) on January 15, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as expressly set forth in this Amendment No. 1, all terms of the License Agreement shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment No. 1 may be executed
in one or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same
instrument. This Amendment No. 1, to the extent signed and delivered by means of a facsimile machine or by exchanging PDF signatures,
shall be treated in all manner and respects and for all purposes as an original agreement or instrument and shall be considered
to have the same binding legal effect as if it were the original signed version thereof delivered in person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS</B> whereof
the Parties hereto have caused this Amendment No. 1 to be signed by their duly authorized officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Signed for and on behalf of</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Signed for and on behalf of</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><B>Plasma Technologies LLC</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>PlasmaTech Biopharmaceuticals, Inc.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-decoration: underline; text-align: justify; border-bottom: Black 1pt solid"><U STYLE="text-decoration: none">/s/ Eugene J. Zurlo</U></TD>
    <TD STYLE="text-align: justify; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-decoration: underline; text-align: justify; border-bottom: Black 1pt solid"><U STYLE="text-decoration: none">/s/ Steven H. Rouhandeh</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: justify">Name:</TD>
    <TD STYLE="width: 38%; text-align: justify">Eugene J. Zurlo</TD>
    <TD STYLE="width: 12%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 6%; text-align: justify">Name:</TD>
    <TD STYLE="width: 38%; text-align: justify">Steven H. Rouhandeh</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Manager</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chairman</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I>&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
